The vast majority of estrogen-dependent breast cancers do not grow or metastasize in conventional PDX host strains (12, 13), with the largest study reporting a 2.5% engraftment rate of therapy-naïve luminal ER+ breast tumor xenografts (13). Here, ESR1 is linked to breast carcinoma.